procainamide has been researched along with Recrudescence in 52 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 30 patients who developed atrial fibrillation after open-heart surgery the efficacy of intravenous procainamide was evaluated and compared with standard acute digoxin digitalisation." | 9.07 | Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. ( Hjelms, E, 1992) |
| "Seven patients with chronic or recurrent supraventricular tachyarrhythmias were selected for a trial of antazoline therapy because sinus rhythm or a controlled ventricular response could not be achieved with quinidine, procainamide, digitalis or propranolol." | 9.04 | Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report. ( Downar, E; Waxman, MB, 1975) |
| "The electrophysiologic and electrocardiographic effects of intravenous pirmenol were compared with intravenous procainamide in 17 patients with symptomatic ventricular tachycardia." | 7.67 | The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide. ( Frumin, H; Gold, RL; Haffajee, CI; Jarandilla, R; Kerin, NZ, 1988) |
| "We compared the relationship between plasma levels of procainamide and suppression or prevention of various forms of ventricular arrhythmias in 18 patients, six of whom had premature ventricular complexes (PVCs) during acute myocardial infarction (AMI), six of whom had PVCs in the setting of stable chronic ischemic heart disease (CIHD), and six of whom had recurrent symptomatic ventricular tachycardia (VT) with chronic PVCs between episodes of VT." | 7.66 | Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. ( Castellanos, A; Conde, CA; Cooper, D; Kessler, KM; Kiem, I; Myerburg, RJ; Pefkaros, KC, 1981) |
| "Brugada syndrome is a clinical and electrocardiographic entity characterized by ST segment elevation in the right precordial ECG leads and sudden death or syncope secondary to malignant ventricular arrhythmia, and has a high recurrence rate." | 5.32 | [Recurrent ventricular fibrillation in a patient with Brugada syndrome successfully treated with procainamide]. ( Merino, JL; Peinado, A; Peinado, R; Sánchez-Aquino, RM; Sobrino, JA, 2003) |
| "In 30 patients who developed atrial fibrillation after open-heart surgery the efficacy of intravenous procainamide was evaluated and compared with standard acute digoxin digitalisation." | 5.07 | Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. ( Hjelms, E, 1992) |
| "Seven patients with chronic or recurrent supraventricular tachyarrhythmias were selected for a trial of antazoline therapy because sinus rhythm or a controlled ventricular response could not be achieved with quinidine, procainamide, digitalis or propranolol." | 5.04 | Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report. ( Downar, E; Waxman, MB, 1975) |
| "In order to determine the efficacy of type 1C agents (flecainide, encainide, propafenone) in patients with atrial fibrillation who have failed to maintain sinus rhythm with type 1A agents (quinidine, procainamide, disopyramide), 147 patients, that were admitted into the John Dempsey Hospital with new or recurrent atrial fibrillation between 1987-1991, were studied retrospectively." | 3.68 | Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation. ( Grey, E; Silverman, DI, 1993) |
| "The electrophysiologic and electrocardiographic effects of intravenous pirmenol were compared with intravenous procainamide in 17 patients with symptomatic ventricular tachycardia." | 3.67 | The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide. ( Frumin, H; Gold, RL; Haffajee, CI; Jarandilla, R; Kerin, NZ, 1988) |
| " Twenty-six of these patients, who had ventricular fibrillation during single-drug therapy with quinidine, procainamide, or disopyramide, were compared with a control group of 62 patients who had been treated similarly for ventricular arrhythmias but did not have ventricular fibrillation during treatment." | 3.67 | Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. ( Heger, JJ; Miles, WM; Minardo, JD; Prystowsky, EN; Zipes, DP, 1988) |
| "We compared the relationship between plasma levels of procainamide and suppression or prevention of various forms of ventricular arrhythmias in 18 patients, six of whom had premature ventricular complexes (PVCs) during acute myocardial infarction (AMI), six of whom had PVCs in the setting of stable chronic ischemic heart disease (CIHD), and six of whom had recurrent symptomatic ventricular tachycardia (VT) with chronic PVCs between episodes of VT." | 3.66 | Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia. ( Castellanos, A; Conde, CA; Cooper, D; Kessler, KM; Kiem, I; Myerburg, RJ; Pefkaros, KC, 1981) |
| " Lidocaine was effective in terminating acute symptomatic attacks; procaine amide and propranolol were effective in long-term control of the arrhythmia." | 3.65 | Idiopathic paroxysmal ventricular tachycardia in infants and children. ( Goldring, D; Hernandez, A; Kleiger, RE; Strauss, A, 1975) |
| " In 78 per cent of the cases, atrial fibrillation recurred by the end of 12 months in spite of the administration of quinidine or procainamide or propranolol, singly or combined." | 3.65 | Maintenance of sinus rhythm after atrial defibrillation. ( Batson, GA; Sideris, DA; Szekely, P, 1970) |
| "Procainamide 10 mg/kg was given intravenously with an injection speed of 100 mg/min, and lidocaine was administered at an intravenous dose of 1." | 2.68 | Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. ( Gorgels, AP; Hofs, A; Mulleneers, R; Smeets, JL; van den Dool, A; Vos, MA; Wellens, HJ, 1996) |
| "This study assessed the efficacy of the combination of sotalol and either quinidine or procainamide in preventing sustained ventricular tachycardia inducibility and recurrence and prospectively evaluated the ability of the drug combination to prevent ventricular tachycardia recurrence when the arrhythmia remained inducible but was modified." | 2.67 | Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. ( Berman, N; Dorian, P; Hardy, J; Mitchell, J; Newman, D, 1993) |
| "Adenosine has been well studied as a mainstay treatment, but the methods of adenosine administration have not been very well delineated." | 1.38 | Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. ( Goodman, IS; Lu, CJ, 2012) |
| "Brugada syndrome is a clinical and electrocardiographic entity characterized by ST segment elevation in the right precordial ECG leads and sudden death or syncope secondary to malignant ventricular arrhythmia, and has a high recurrence rate." | 1.32 | [Recurrent ventricular fibrillation in a patient with Brugada syndrome successfully treated with procainamide]. ( Merino, JL; Peinado, A; Peinado, R; Sánchez-Aquino, RM; Sobrino, JA, 2003) |
| "Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
| "There were no recurrences of ventricular arrhythmias, and patients did not require antiarrhythmic drug therapy." | 1.28 | Surgical intervention for drug-resistant ventricular tachycardia. ( Barker, RA; Gardner, MA; Landymore, RW; McIntyre, AJ, 1990) |
| "Forty-five patients survived a cardiac arrest due to ventricular tachycardia (VT) or ventricular fibrillation (VF)." | 1.27 | Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. ( Hess, DS; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| "Mexiletine was combined with a conventional type IA antiarrhythmic agent in 25 patients (49%)." | 1.27 | Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. ( Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA, 1986) |
| "Lorcainide was tested acutely in all 38 patients and prevented ventricular tachycardia (VT) or ventricular fibrillation (VF) induction in 14 patients and failed in 24 (efficacy rate 37%)." | 1.27 | Lorcainide therapy in a cardiac arrest population. ( Keefe, D; Laux, B; Miura, DS; Somberg, JC; Wynn, J, 1986) |
| "The place of pacemakers in the treatment of tachyarrhythmias has expanded far beyond the initial role in the brady-tachy syndrome, of providing a "minimum guaranteed rate" while medications suppress the tachycardia." | 1.26 | Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. ( Altschuler, H; Cohen, HL; Escher, DJ; Fisher, JD; Furman, S; Mehra, R, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (65.38) | 18.7374 |
| 1990's | 11 (21.15) | 18.2507 |
| 2000's | 5 (9.62) | 29.6817 |
| 2010's | 1 (1.92) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Nauchi, M | 1 |
| Yamawaki, M | 1 |
| Nakano, T | 1 |
| Makino, K | 1 |
| Honda, Y | 1 |
| Sakai, T | 1 |
| Ito, Y | 1 |
| Goodman, IS | 1 |
| Lu, CJ | 1 |
| Mattioli, AV | 1 |
| Bonatti, S | 1 |
| Bonetti, L | 1 |
| Mattioli, G | 1 |
| Gouin, S | 1 |
| Ali, S | 1 |
| Lee, JK | 2 |
| Klein, GJ | 2 |
| Krahn, AD | 2 |
| Yee, R | 2 |
| Zarnke, K | 2 |
| Simpson, C | 2 |
| Skanes, A | 2 |
| Sánchez-Aquino, RM | 1 |
| Peinado, R | 1 |
| Peinado, A | 1 |
| Merino, JL | 1 |
| Sobrino, JA | 1 |
| Myerburg, RJ | 3 |
| Zaman, L | 1 |
| Kessler, KM | 2 |
| Castellanos, A | 3 |
| Kasanuki, H | 1 |
| Ohnishi, S | 1 |
| Hirosawa, K | 1 |
| Morady, F | 2 |
| Scheinman, MM | 1 |
| Hess, DS | 1 |
| Sung, RJ | 2 |
| Shen, E | 1 |
| Shapiro, W | 1 |
| Citone, C | 1 |
| Di Marcotullio, G | 1 |
| Polizzi, C | 1 |
| Uguccioni, M | 1 |
| Carelli, M | 1 |
| Masini, V | 1 |
| Welch, WJ | 1 |
| Strasberg, B | 1 |
| Coelho, A | 1 |
| Rosen, KM | 1 |
| Kiem, I | 2 |
| Pefkaros, KC | 1 |
| Conde, CA | 1 |
| Cooper, D | 1 |
| Kesler, DF | 1 |
| Herling, IM | 1 |
| Horowitz, LN | 2 |
| Josephson, ME | 2 |
| Grey, E | 1 |
| Silverman, DI | 1 |
| Kushakovskiĭ, MS | 1 |
| Iakubovich, II | 1 |
| Kuz'min, AP | 1 |
| Dorian, P | 1 |
| Newman, D | 1 |
| Berman, N | 1 |
| Hardy, J | 1 |
| Mitchell, J | 1 |
| Gorgels, AP | 1 |
| van den Dool, A | 1 |
| Hofs, A | 1 |
| Mulleneers, R | 1 |
| Smeets, JL | 1 |
| Vos, MA | 1 |
| Wellens, HJ | 2 |
| Daoud, EG | 1 |
| Knight, BP | 1 |
| Weiss, R | 1 |
| Bahu, M | 1 |
| Paladino, W | 1 |
| Goyal, R | 1 |
| Man, KC | 1 |
| Strickberger, SA | 1 |
| Hirata, K | 1 |
| Takagi, Y | 1 |
| Nakada, M | 1 |
| Kyushima, M | 1 |
| Asato, H | 1 |
| Humphries, JO | 1 |
| Fujiki, A | 1 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Mizumaki, K | 1 |
| Hayashi, H | 1 |
| Inoue, H | 1 |
| Spindler, B | 1 |
| Lown, B | 1 |
| Matta, RJ | 1 |
| Besser, HW | 1 |
| Fisher, JD | 1 |
| Cohen, HL | 1 |
| Mehra, R | 1 |
| Altschuler, H | 1 |
| Escher, DJ | 1 |
| Furman, S | 1 |
| Conde, C | 1 |
| Sheps, DS | 1 |
| Appel, RA | 1 |
| Reddy, CP | 1 |
| Gettes, LS | 1 |
| Mason, JW | 1 |
| Winkle, RA | 2 |
| Farshidi, A | 1 |
| Spielman, SR | 1 |
| Michelson, EL | 1 |
| Greenspan, AM | 1 |
| Alderman, EL | 1 |
| Fitzgerald, JW | 1 |
| Harrison, DC | 1 |
| Kahn, A | 1 |
| Morris, JJ | 1 |
| Citron, P | 1 |
| Downar, E | 1 |
| Waxman, MB | 1 |
| Hernandez, A | 1 |
| Strauss, A | 1 |
| Kleiger, RE | 1 |
| Goldring, D | 1 |
| Hjelms, E | 1 |
| Hallstrom, AP | 1 |
| Cobb, LA | 1 |
| Yu, BH | 1 |
| Weaver, WD | 1 |
| Fahrenbruch, CE | 2 |
| Landymore, RW | 1 |
| Gardner, MA | 1 |
| McIntyre, AJ | 1 |
| Barker, RA | 1 |
| Gold, RL | 1 |
| Frumin, H | 1 |
| Haffajee, CI | 1 |
| Kerin, NZ | 1 |
| Jarandilla, R | 1 |
| Grubb, BP | 1 |
| Minardo, JD | 1 |
| Heger, JJ | 1 |
| Miles, WM | 1 |
| Zipes, DP | 1 |
| Prystowsky, EN | 1 |
| Poole, JE | 1 |
| Werner, JA | 1 |
| Bardy, GH | 1 |
| Graham, EL | 1 |
| Pulaski, WP | 1 |
| Greene, HL | 1 |
| Buchanan, D | 1 |
| Gillette, PC | 1 |
| Zinner, A | 1 |
| Crawford, F | 1 |
| Somberg, JC | 1 |
| Laux, B | 1 |
| Wynn, J | 1 |
| Keefe, D | 1 |
| Miura, DS | 1 |
| Lim, CH | 1 |
| Toh, CC | 1 |
| Chia, BL | 1 |
| Chung, EK | 1 |
| Gmeiner, R | 1 |
| Dienstl, F | 1 |
| Videbaek, J | 1 |
| Andersen, ED | 1 |
| Jacobsen, JR | 1 |
| Sandoe, E | 1 |
| Wennevold, A | 1 |
| Goolsby, JP | 1 |
| Oliva, PB | 1 |
| Vlessing, E | 1 |
| Manejwala, BG | 1 |
| Knouse, AB | 1 |
| Hidalgo, HH | 1 |
| Szekely, P | 1 |
| Sideris, DA | 1 |
| Batson, GA | 1 |
| Storstein, O | 1 |
| Dhurandhar, RW | 1 |
| Teasdale, SJ | 1 |
| Mahon, WA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Subclinical Postoperative Atrial Fibrillation[NCT02522364] | 150 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | |||
| Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306] | 150 participants (Anticipated) | Interventional | 2013-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for procainamide and Recrudescence
| Article | Year |
|---|---|
Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery B | 1998 |
Cardiac arrhythmias. Rationale of drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Bretylium Compounds; Cardiac Gl | 1973 |
7 trials available for procainamide and Recrudescence
| Article | Year |
|---|---|
Left atrial size after cardioversion for atrial fibrillation: effect of external direct current shock.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, Left; Blood Flow Velocity | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fib | 2003 |
Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Ma | 1993 |
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Male | 1996 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; | 2000 |
Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report.
Topics: Adolescent; Adult; Aged; Antazoline; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic | 1975 |
Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Blood Pressure; Cardiac Surgical Procedures; Digoxin; | 1992 |
43 other studies available for procainamide and Recrudescence
| Article | Year |
|---|---|
Bedside Electrophysiological Study Using a Temporary Pacemaker May Predict Recurrence of Atrioventricular Block After Transcatheter Aortic Valve Replacement.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Aortic Valve Stenosis; | 2021 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Com | 2012 |
A patient with chaotic atrial tachycardia.
Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality | 2003 |
[Recurrent ventricular fibrillation in a patient with Brugada syndrome successfully treated with procainamide].
Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Death, Sudden, Cardiac; Defibrillators, Implantable; El | 2003 |
Evolving concepts of management of stable and potentially lethal arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; Dose-Response Relationship, Dr | 1982 |
Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrocardiogr | 1983 |
Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
Topics: Adult; Aged; Death, Sudden; Electrophysiology; Female; Heart Arrest; Humans; Male; Middle Aged; Pati | 1983 |
[Effectiveness of pharmacological prevention after the first attack of ventricular tachycardia].
Topics: Heart Ventricles; Humans; Lidocaine; Procainamide; Quinidine; Recurrence; Tachycardia | 1982 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procaina | 1982 |
Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
Topics: Acute Disease; Aged; Chronic Disease; Coronary Disease; Dose-Response Relationship, Drug; Electrocar | 1981 |
[Prevention of frequent paroxysmal ventricular tachycardia by combined use of anti-arrhythmia drugs].
Topics: Aged; Alprenolol; Anti-Arrhythmia Agents; Drug Therapy, Combination; Humans; Lanatosides; Male; Midd | 1981 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe | 1980 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Hear | 1993 |
[The rate of recovery of left atrial contractile function after the transition to sinus rhythm in patients with paroxysmal atrial fibrillation].
Topics: Adult; Aged; Atrial Fibrillation; Atrial Function, Left; Drug Therapy, Combination; Electric Counter | 1995 |
Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cardiac Pacing, Artificial; Ele | 1997 |
Beat-to-beat variation of the ST segment in a patient with right bundle branch block, persistent ST segment elevation, and ventricular fibrillation: a case report.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Electric Countershock; Electrocardiography; Hear | 1998 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |
Programmed "trendscription." A new approach to electrocardiographic monitoring.
Topics: Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Benzamides; Cardiac Complexes, Premature; | 1975 |
Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Complexes, Premature; | 1977 |
Antiarrhythmic drug therapy in survivors of prehospital cardiac arrest: comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest.
Topics: Adult; Aged; Arrhythmias, Cardiac; Death, Sudden; Drug Evaluation; Electrocardiography; Female; Foll | 1979 |
Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Electric Stimulation; Exercise Test; Female; Heart Rate; H | 1979 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Treatment of recurrent symptomatic ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Drug Evaluation; Female; He | 1976 |
Patient-initiated rapid atrial pacing to manage supraventricular tachycardia.
Topics: Adult; Aged; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Male; Middle Aged; Pacemaker, Artific | 1976 |
Idiopathic paroxysmal ventricular tachycardia in infants and children.
Topics: Adolescent; Arrhythmias, Cardiac; Child; Child, Preschool; Drug Therapy, Combination; Electrocardiog | 1975 |
Pathophysiology of ventricular tachycardia in man.
Topics: Chronic Disease; Electric Stimulation; Electrocardiography; Heart Ventricles; Humans; Myocardial Inf | 1975 |
An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985.
Topics: Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Death, Sudden, Cardiac; Heart Arrest; Humans; | 1991 |
Surgical intervention for drug-resistant ventricular tachycardia.
Topics: Adult; Aged; Drug Resistance; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged | 1990 |
The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Electric Stimulation; | 1988 |
Recurrence of ventricular tachycardia after conversion from proprietary to generic procainamide.
Topics: Humans; Male; Middle Aged; Procainamide; Recurrence; Tachycardia; Therapeutic Equivalency | 1989 |
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Diuretics; Drug Th | 1988 |
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophy | 1986 |
Ventricular tachydysrhythmias in near-miss sudden infant death syndrome.
Topics: Amiodarone; Heart Ventricles; Humans; Infant, Newborn; Infusions, Parenteral; Male; Procainamide; Pr | 1986 |
Lorcainide therapy in a cardiac arrest population.
Topics: Arrhythmias, Cardiac; Benzeneacetamides; Blood Pressure; Cardiac Pacing, Artificial; Electrocardiogr | 1986 |
Ventricular fibrillation in type B Wolff-Parkinson-White syndrome.
Topics: Adult; Female; Humans; Lidocaine; Pacemaker, Artificial; Practolol; Procainamide; Recurrence; Ventri | 1974 |
[Ventricular tachycardia due to re-entry mechanism via the bundle branches].
Topics: Aged; Electrocardiography; Heart Conduction System; Humans; Lidocaine; Male; Myocardial Infarction; | 1973 |
Paroxysmal tachycardia in infancy and childhood. II. Paroxysmal ventricular tachycardia and fibrillation.
Topics: Cardiomyopathies; Child; Child, Preschool; Digoxin; Electrocardiography; Female; Follow-Up Studies; | 1973 |
Electrocardiographic and clinical observations of a recurrent tachyarrhythmia arising from a pacemaker within the distribution of the anterior fascicle.
Topics: Bundle-Branch Block; Digitalis; Electric Countershock; Electrocardiography; Heart Atria; Heart Condu | 1974 |
Multiple episodes of ventricular fibrillation in acute myocardial infarction.
Topics: Acute Disease; Electric Countershock; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; P | 1972 |
Maintenance of sinus rhythm after atrial defibrillation.
Topics: Atrial Fibrillation; Delayed-Action Preparations; Drug Therapy, Combination; Electric Countershock; | 1970 |
[Recurrent ventricular tachycardia].
Topics: Humans; Pacemaker, Artificial; Procainamide; Recurrence; Sympathectomy; Tachycardia, Paroxysmal | 1970 |
Bretylium tosylate in the management of refractory ventricular fibrillation.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl | 1971 |